RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hanmi Science Co Stock

Hanmi Science Co P/E 2024

Hanmi Science Co P/E

21.81

Ticker

008930.KS

ISIN

KR7008930000

As of Sep 26, 2024, Hanmi Science Co's P/E ratio was 21.81, a -52.73% change from the 46.14 P/E ratio recorded in the previous year.

The Hanmi Science Co P/E history

Hanmi Science Co Aktienanalyse

What does Hanmi Science Co do?

Hanmi Science Co Ltd is a South Korean company specializing in the manufacturing of pharmaceutical products, biologics, and medical devices. The company was founded in 1973 as a chemical company and obtained the license for drug manufacturing in 1990, expanding its product range to include pharmaceuticals. Today, the company's business model includes three main areas: research and development, manufacturing and sales of drugs, and sales of medical devices. Hanmi aims to develop and produce innovative and high-quality products to improve people's health worldwide. In the field of research and development, Hanmi Science is a leading company. It specializes in the research and development of novel drugs and biologics. The company has an impressive track record in the development and marketing of innovative drugs for the treatment of diabetes, cancer, and rare diseases. This includes a range of biosimilars produced using biotechnological methods that are more affordable compared to original medical substances. Hanmi also has a state-of-the-art production infrastructure that meets the highest quality standards and ensures reliable supply. In the field of drug manufacturing, the company produces generics and biosimilars that are sold in more than 50 countries worldwide. Hanmi also specializes in the production of chemotherapeutics and parenteral drugs that have proven efficacy and safety. The medical device sales division focuses on marketing high-quality medical devices, including diagnostic and monitoring devices used in the medical field. Hanmi also distributes a range of medical consumables, including transfusion sets, syringes, infusion sets, and catheters. Hanmi Science Co Ltd offers a wide range of products that can be categorized into various categories. Among the pharmaceutical products are antidiabetic drugs, anticancer agents, antidepressants, antibiotics, antiviral medications, and products for the treatment of rare diseases. The portfolio also includes biosimilars of botulinum toxin, insulin, and humiderm among the biologics. Overall, Hanmi Science Co Ltd holds a strong position in the South Korean market and has also established a good reputation internationally. With its focus on research and development and the production of high-quality drugs and medical devices, the company has a promising future. Hanmi Science Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Hanmi Science Co's P/E Ratio

The Price to Earnings (P/E) Ratio of Hanmi Science Co is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Hanmi Science Co's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Hanmi Science Co is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Hanmi Science Co’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Hanmi Science Co stock

What is the price-to-earnings ratio of Hanmi Science Co?

The price-earnings ratio of Hanmi Science Co is currently 21.81.

How has the price-earnings ratio of Hanmi Science Co changed compared to last year?

The price-to-earnings ratio of Hanmi Science Co has increased by -52.73% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Hanmi Science Co high compared to other companies?

Yes, the price-to-earnings ratio of Hanmi Science Co is high compared to other companies.

How does an increase in the price-earnings ratio of Hanmi Science Co affect the company?

An increase in the price-earnings ratio of Hanmi Science Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Hanmi Science Co affect the company?

A decrease in the price-earnings ratio of Hanmi Science Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Hanmi Science Co?

Some factors that influence the price-earnings ratio of Hanmi Science Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Hanmi Science Co pay?

Over the past 12 months, Hanmi Science Co paid a dividend of 200 KRW . This corresponds to a dividend yield of about 0.61 %. For the coming 12 months, Hanmi Science Co is expected to pay a dividend of 200 KRW.

What is the dividend yield of Hanmi Science Co?

The current dividend yield of Hanmi Science Co is 0.61 %.

When does Hanmi Science Co pay dividends?

Hanmi Science Co pays a quarterly dividend. This is distributed in the months of January, January, January, July.

How secure is the dividend of Hanmi Science Co?

Hanmi Science Co paid dividends every year for the past 7 years.

What is the dividend of Hanmi Science Co?

For the upcoming 12 months, dividends amounting to 200 KRW are expected. This corresponds to a dividend yield of 0.61 %.

In which sector is Hanmi Science Co located?

Hanmi Science Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hanmi Science Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hanmi Science Co from 8/14/2024 amounting to 100 KRW, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Hanmi Science Co pay the last dividend?

The last dividend was paid out on 8/14/2024.

What was the dividend of Hanmi Science Co in the year 2023?

In the year 2023, Hanmi Science Co distributed 196.078 KRW as dividends.

In which currency does Hanmi Science Co pay out the dividend?

The dividends of Hanmi Science Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hanmi Science Co

Our stock analysis for Hanmi Science Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hanmi Science Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.